Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1964;31(6):825-34.

COMPARISON OF IMMUNE MECHANISMS IN VARIOUS EXPERIMENTAL MODELS OF CHOLERA

COMPARISON OF IMMUNE MECHANISMS IN VARIOUS EXPERIMENTAL MODELS OF CHOLERA

R FRETER. Bull World Health Organ. 1964.

Abstract

Two of the main features of human cholera-induction of diarrhoea and confinement of the infection to the lumen of the intestinal tract-may be reproduced in three experimental models: (a) the streptomycin-treated, starved guinea-pig; (b) the intestinal loop in the adult rabbit; and (c) the suckling rabbit. In this paper the author compares the two last-mentioned models with his earlier work in guinea-pigs.Intestinal antibody (coproantibody) was highly protective, while circulating antibody had little or no effect, in all three models. The protective coproantibody was specific for the heat-stable vibrio antigens. It did not affect the growth of vibrios in the intestine, and its function may possibly be regarded as antitoxic rather than antibacterial. Oral vaccination protected adult rabbits against challenge by the loop technique. Heat-killed vaccine was as effective in this respect as live vaccine.The author feels that the present uncertainty concerning the protective value of cholera vaccination may be due to the fact that conventional vaccine is designed to induce high serum titres only. He considers that since oral vaccine has been shown to induce and maintain the production of coproantibody in human volunteers, a field trial should be carried out to determine whether coproantibody is as protective in man as it has proved to be in the experimental models.

PubMed Disclaimer

References

    1. Br J Exp Pathol. 1960 Feb;41:24-30 - PubMed
    1. J Exp Med. 1956 Sep 1;104(3):411-8 - PubMed
    1. J Bacteriol. 1963 Feb;85(2):497-8 - PubMed
    1. J Infect Dis. 1964 Feb;114:26-30 - PubMed
    1. Br J Pharmacol Chemother. 1955 Jun;10(2):153-9 - PubMed

LinkOut - more resources